The nation’s biggest pharmacy benefits manager has decided to cover two new drugs that lower artery-clogging cholesterol but raise concern over prices that can top $14,000 a year. Express Scripts said Tuesday that it will pay for prescriptions of Amgen Inc.’s Repatha as well as Praluent from Sanofi and Regeneron Pharmaceuticals Inc. under a few conditions designed to control costs.
Are you up for a challenge?
